China-Japan Friendship Hospital Drug Clinical Trial Center

The Clinical Trial Institute for Drugs at the Hospital of China was established in 1990 and, in August 2017, renamed the China Friendly Hospital Clinical Trial Research Center (CCTR), approved by Beijing City Research Unit in 2022. The GCP Center uniquely manages the entire medical facility of medicines, medical devices, clinical trials and post-marketing studies for registered diagnostic agents and applicants.The GCP Center has established institutional offices, Phase I clinical trial research facilities, quality control and data statistics centers. GCP Centres adhere to the concept of high-quality clinical trial care, establish a full-chain clinical trial service platform, focus on significantly improving service capacity and efficiency, continuously improve technical service capabilities, drive high-quality clinical trial development. Based on the strength of the inpatient respiratory, endocrine, skin, pain, and other subject groups, GCP centers and clinical specialties have now become a major force in our country's clinical trial team, with 25 existing drug clinical trial specialists, main researchers PI71; 45 specialists in machine clinical trials, main researchers PI269;;